These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11264218)

  • 1. Undertreatment of heart failure has high cost to patients.
    Berry C; McMurray J
    BMJ; 2001 Mar; 322(7288):731-2. PubMed ID: 11264218
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on treatment for congestive heart failure.
    Sucov A
    Med Health R I; 2002 Feb; 85(2):64-5. PubMed ID: 11881170
    [No Abstract]   [Full Text] [Related]  

  • 3. Overview of current chronic heart failure therapy.
    Moore CK
    J Miss State Med Assoc; 2000 Apr; 41(4):549-51. PubMed ID: 10790951
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for chronic heart failure.
    Med Lett Drugs Ther; 1999 Jan; 41(1045):12-4. PubMed ID: 9949763
    [No Abstract]   [Full Text] [Related]  

  • 5. New therapies for heart failure.
    Riggs JM
    RN; 2004 Mar; 67(3):28-32; quiz 33. PubMed ID: 15065491
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharma-clinics. How I treat...symptomatic heart failure].
    Kulbertus H
    Rev Med Liege; 1999 Jul; 54(7):625-8. PubMed ID: 10495687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical inquiries. What is the most effective beta-blocker for heart failure?
    Neher JO; Safranek S; Grover F
    J Fam Pract; 2003 May; 52(5):396, 398-9. PubMed ID: 12737773
    [No Abstract]   [Full Text] [Related]  

  • 8. Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.
    de Peuter OR; Lip GY; Souverein PC; Klungel OH; de Boer A; Büller HR; Kamphuisen PW
    Eur J Heart Fail; 2011 May; 13(5):489-95. PubMed ID: 21193438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Administration of beta blockers for chronic heart failure].
    Walma EP
    Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2325-6. PubMed ID: 11143301
    [No Abstract]   [Full Text] [Related]  

  • 10. When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
    Ahmad T; Patel CB; Milano CA; Rogers JG
    Circulation; 2012 Jun; 125(23):2948-55. PubMed ID: 22689932
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination therapy of beta blockers for heart failure].
    Watanabe M; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
    Weir RA; McMurray JJ; Puu M; Solomon SD; Olofsson B; Granger CB; Yusuf S; Michelson EL; Swedberg K; Pfeffer MA;
    Eur J Heart Fail; 2008 Feb; 10(2):157-63. PubMed ID: 18242128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.
    Porcu M
    Ital Heart J; 2002 Jul; 3(7):437-8. PubMed ID: 12189976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combination therapy with ARB for heart failure].
    Sakata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():123-7. PubMed ID: 17569310
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic heart failure. Diagnosis and therapy].
    Schwinger RH
    Med Monatsschr Pharm; 2000 May; 23(5):142-8. PubMed ID: 10838829
    [No Abstract]   [Full Text] [Related]  

  • 16. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract]   [Full Text] [Related]  

  • 17. An old drug provides surprising benefits for heart-failure patients.
    Harv Heart Lett; 1999 Dec; 10(4):5-7. PubMed ID: 10564892
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker.
    Berry C; Murphy NF; De Vito G; Galloway S; Seed A; Fisher C; Sattar N; Vallance P; Hillis WS; McMurray J
    Eur J Heart Fail; 2007 Apr; 9(4):429-34. PubMed ID: 17126073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of heart failure in The Netherlands.
    Jaarsma T; Haaijer-Ruskamp FM; Sturm H; Van Veldhuisen DJ
    Eur J Heart Fail; 2005 Mar; 7(3):371-5. PubMed ID: 15718177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.